Magnetar Financial’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $228K | Buy |
+799
| New | +$263K | ﹤0.01% | 854 |
|
|
2025
Q2 | – | Sell |
-4,432
| Closed | -$1.93M | – | 962 |
|
|
2025
Q1 | $1.93M | Buy |
4,432
+2,471
| +126% | +$992K | 0.03% | 279 |
|
|
2024
Q4 | $723K | Sell |
1,961
-7,485
| -79% | -$3.13M | 0.02% | 313 |
|
|
2024
Q3 | $4.91M | Buy |
9,446
+1,638
| +21% | +$875K | 0.11% | 153 |
|
|
2024
Q2 | $4.23M | Buy |
7,808
+6,558
| +525% | +$3.47M | 0.09% | 136 |
|
|
2024
Q1 | $648K | Buy |
+1,250
| New | +$622K | 0.01% | 284 |
|
|
2023
Q4 | – | Sell |
-5,891
| Closed | -$2.57M | – | 422 |
|
|
2023
Q3 | $2.57M | Buy |
5,891
+1,851
| +46% | +$840K | 0.07% | 164 |
|
|
2023
Q2 | $1.79M | Sell |
4,040
-3,126
| -44% | -$1.44M | 0.04% | 226 |
|
|
2023
Q1 | $3.29M | Sell |
7,166
-60,382
| -89% | -$28.7M | 0.06% | 215 |
|
|
2022
Q4 | $34.6M | Buy |
+67,548
| New | +$34.3M | 0.59% | 42 |
|
|
2020
Q3 | – | Sell |
-2,656
| Closed | -$698K | – | 670 |
|
|
2020
Q2 | $698K | Buy |
+2,656
| New | +$709K | 0.02% | 233 |
|
|
2020
Q1 | – | Sell |
-17,710
| Closed | -$5.35M | – | 521 |
|
|
2019
Q4 | $5.35M | Buy |
+17,710
| New | +$4.87M | 0.11% | 115 |
|
|
2019
Q2 | – | Sell |
-1,195
| Closed | -$343K | – | 482 |
|
|
2019
Q1 | $343K | Buy |
+1,195
| New | +$346K | 0.01% | 305 |
|
|
2018
Q4 | – | Sell |
-2,041
| Closed | -$559K | – | 354 |
|
|
2018
Q3 | $559K | Buy |
+2,041
| New | +$530K | 0.01% | 178 |
|
|
2018
Q2 | – | Sell |
-3,276
| Closed | -$720K | – | 554 |
|
|
2018
Q1 | $720K | Buy |
+3,276
| New | +$770K | 0.01% | 272 |
|
|
2017
Q4 | – | Sell |
-1,854
| Closed | -$352K | – | 753 |
|
|
2017
Q3 | $352K | Sell |
1,854
-14,376
| -89% | -$2.74M | 0.01% | 499 |
|
|
2017
Q2 | $3.05M | Buy |
+16,230
| New | +$2.92M | 0.05% | 174 |
|
|
2016
Q4 | – | Sell |
-9,573
| Closed | -$1.2M | – | 134 |
|
|
2016
Q3 | $1.2M | Buy |
9,573
+4,185
| +78% | +$540K | 0.02% | 241 |
|
|
2016
Q2 | $708K | Buy |
+5,388
| New | +$737K | 0.01% | 189 |
|
|
2016
Q1 | – | Sell |
-3,201
| Closed | -$446K | – | 399 |
|
|
2015
Q4 | $446K | Buy |
+3,201
| New | +$441K | 0.01% | 160 |
|
|
2015
Q3 | – | Sell |
-5,294
| Closed | -$869K | – | 438 |
|
|
2015
Q2 | $869K | Sell |
5,294
-9,503
| -64% | -$1.52M | 0.01% | 187 |
|
|
2015
Q1 | $2.29M | Buy |
+14,797
| New | +$2.11M | 0.04% | 144 |
|
|
2014
Q4 | – | Sell |
-12,048
| Closed | -$1.44M | – | 195 |
|
|
2014
Q3 | $1.44M | Buy |
+12,048
| New | +$1.38M | 0.02% | 147 |
|
Other funds holding ELV
VCM
VPM
Magnetar Financial's ELV Position: Q1 2026 in Review
Magnetar Financial opened a new position in Elevance Health (ELV) in Q1 2026: 799 shares worth $228K. The stake represents ﹤0.01% of the portfolio and ranks #854 among its holdings. This is a return to the name: Magnetar Financial previously reported a position in ELV as recently as Q1 2025.
Magnetar Financial first reported a position in ELV in Q3 2014 and has held it in 23 quarters since. The position peaked at $34.6M in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Magnetar Financial held 799 shares of Elevance Health worth $228K as of Q1 2026.
- Elevance Health was a new Magnetar Financial position in Q1 2026.
- Elevance Health made up ﹤0.01% of Magnetar Financial's portfolio in Q1 2026, its #854 holding.
- Magnetar Financial first reported a position in Elevance Health in Q3 2014 and has held it in 23 quarters since.
- Magnetar Financial's Elevance Health position peaked at $34.6M in Q4 2022.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Magnetar Financial's 13F filing for Q1 2026, filed 13 May 2026.